中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2015年
3期
45-48
,共4页
徐胜%黄顺荣%麦威%钟晓刚%李雷%王晓通
徐勝%黃順榮%麥威%鐘曉剛%李雷%王曉通
서성%황순영%맥위%종효강%리뢰%왕효통
胃癌%胃癌根治术%无结扎外科技术%电外科
胃癌%胃癌根治術%無結扎外科技術%電外科
위암%위암근치술%무결찰외과기술%전외과
Gastric cancer%Radical gastrectomy%No-ligation surgical techniques%Electrosurgery
目的:探讨无结扎外科技术在胃癌根治术中的临床价值和疗效。方法选择2011年1月~2013年12月广西壮族自治区人民医院行胃癌根治术病例60例,按照手术方式分为无结扎组和传统组,每组各30例。观察两组患者围术期临床疗效和外周血免疫功能变化。结果全部两组病例手术顺利,无术中、术后大出血。无结扎组与传统组手术时间分别为(82.67±17.05)、(93.80±14.55) min,术中出血量分别为(65.50±24.05)、(93.50±35.51)mL,术后平均引流量分别为(136.17±66.13)、(228.77±101.63)mL,两组比较差异均有统计学意义(P<0.05);无结扎组与传统组清扫淋巴结个数分别为(19.16±9.12)、(20.13±7.43)个,平均肛门排气时间分别为(3.90±0.68)、(4.00±0.73)d,术后住院时间分别为(10.87±1.33)、(11.40±1.87)d,两组比较差异均无统计学意义(P>0.05)。术后第1天、术后第7天无结扎组患者血球蛋白水平[(23.88±3.63)、(28.82±4.44)g/L]较传统组[(21.84±3.96)、(25.44±4.23)g/L]显著升高,差异均有统计学意义(P<0.05)。术前、术后第1天、术后第7天两组外周血血红蛋白、红细胞比积、淋巴细胞计数、总蛋白、白蛋白及淋巴细胞计数比较,差异均无统计学意义(P>0.05)。结论无结扎外科技术实施胃癌根治术可避免血管夹、缝线等异物体内存留,与传统胃癌根治术比较可达到相同的肿瘤根治效果,但具有手术时间短、术中出血及术后引流量少、手术创伤小、免疫功能损伤小的优点。
目的:探討無結扎外科技術在胃癌根治術中的臨床價值和療效。方法選擇2011年1月~2013年12月廣西壯族自治區人民醫院行胃癌根治術病例60例,按照手術方式分為無結扎組和傳統組,每組各30例。觀察兩組患者圍術期臨床療效和外週血免疫功能變化。結果全部兩組病例手術順利,無術中、術後大齣血。無結扎組與傳統組手術時間分彆為(82.67±17.05)、(93.80±14.55) min,術中齣血量分彆為(65.50±24.05)、(93.50±35.51)mL,術後平均引流量分彆為(136.17±66.13)、(228.77±101.63)mL,兩組比較差異均有統計學意義(P<0.05);無結扎組與傳統組清掃淋巴結箇數分彆為(19.16±9.12)、(20.13±7.43)箇,平均肛門排氣時間分彆為(3.90±0.68)、(4.00±0.73)d,術後住院時間分彆為(10.87±1.33)、(11.40±1.87)d,兩組比較差異均無統計學意義(P>0.05)。術後第1天、術後第7天無結扎組患者血毬蛋白水平[(23.88±3.63)、(28.82±4.44)g/L]較傳統組[(21.84±3.96)、(25.44±4.23)g/L]顯著升高,差異均有統計學意義(P<0.05)。術前、術後第1天、術後第7天兩組外週血血紅蛋白、紅細胞比積、淋巴細胞計數、總蛋白、白蛋白及淋巴細胞計數比較,差異均無統計學意義(P>0.05)。結論無結扎外科技術實施胃癌根治術可避免血管夾、縫線等異物體內存留,與傳統胃癌根治術比較可達到相同的腫瘤根治效果,但具有手術時間短、術中齣血及術後引流量少、手術創傷小、免疫功能損傷小的優點。
목적:탐토무결찰외과기술재위암근치술중적림상개치화료효。방법선택2011년1월~2013년12월엄서장족자치구인민의원행위암근치술병례60례,안조수술방식분위무결찰조화전통조,매조각30례。관찰량조환자위술기림상료효화외주혈면역공능변화。결과전부량조병례수술순리,무술중、술후대출혈。무결찰조여전통조수술시간분별위(82.67±17.05)、(93.80±14.55) min,술중출혈량분별위(65.50±24.05)、(93.50±35.51)mL,술후평균인류량분별위(136.17±66.13)、(228.77±101.63)mL,량조비교차이균유통계학의의(P<0.05);무결찰조여전통조청소림파결개수분별위(19.16±9.12)、(20.13±7.43)개,평균항문배기시간분별위(3.90±0.68)、(4.00±0.73)d,술후주원시간분별위(10.87±1.33)、(11.40±1.87)d,량조비교차이균무통계학의의(P>0.05)。술후제1천、술후제7천무결찰조환자혈구단백수평[(23.88±3.63)、(28.82±4.44)g/L]교전통조[(21.84±3.96)、(25.44±4.23)g/L]현저승고,차이균유통계학의의(P<0.05)。술전、술후제1천、술후제7천량조외주혈혈홍단백、홍세포비적、림파세포계수、총단백、백단백급림파세포계수비교,차이균무통계학의의(P>0.05)。결론무결찰외과기술실시위암근치술가피면혈관협、봉선등이물체내존류,여전통위암근치술비교가체도상동적종류근치효과,단구유수술시간단、술중출혈급술후인류량소、수술창상소、면역공능손상소적우점。
Objective To investigate the clinical value and efficacy of radical gastrectomy of no-ligation surgical techniques in patients with gastric cancer. Methods 60 cases of patients from January 2011 to December 2013 in the People's Hospital of Guangxi Zhuang Autonomous Region were selected, all patients were given the radical gastrectomy, which were diveded into no-ligation technology group and traditional technology group according to operative method, 30 patients in each group. Postoperative clinical efficacy and immune functional changes in peripheral blood of two groups were observed. Results All the patients were operated successfully, and no intranperative or postoperative massive hemorrhage occurred. In no-ligation technology group and traditional technology group, the operative time were (82.67±17.05), (93.80±14.55) min respectively, the blood loss of operation were (65.50±24.05), (93.50±35.51) mL respectively, and the average volume of drainage were (136.17±66.13), (228.77±101.63) mL respectively, the differences between the two groups were statistically significant (P< 0.05); the number of lymph node dissection were (19.16±9.12), (20.13±7.43) respectively, the average anal exhaust time were (3.90±0.68), (4.00±0.73) d respectively, and postoperative hospital stay were (10.87±1.33), (11.40±1.87) d respectively, there was no statistically significant difference hematocrit, lymphocyte count, total protein, albumin and lymphocyte counts in the two groups was no statistically significant difference (P> 0.05). Conclusion No-ligation surgical technology implemented radical gastrectomy to avoid vascular clips, sutures and other foreign matter in v iv o retention. Comparing with the traditional radical gastrectomy, no-ligation surgical technology can achieve the same effect of tumor cure, and good advantages with shorter operative time, less blood loss and postoperative drainage, less surgery trauma, less damage to the immune function.